Antihistamines and Cancer
by Dr. Paul G. Varnas & WholeHealthAmerica.com (The Better Health News, June, 2010; Volume 7, Issue 6)
Research published in Science News (1994;145:324) raises the question of whether the antihistamines we take for allergies may be linked to cancer. Studies in mice have shown that antihistamines promote the growth of malignant tumors. Scientists at the University of Manitoba believe that the consumption of various medications, including antihistamines and antidepressants, may increase the risk foe cancer. In February 1994, the Department of Health and Human Services noted an increase in the incidence of cancer in the United States. Scientists at the University of Manitoba believe that the consumption of various medications, including antihistamines and antidepressants, may increase the risk for cancer and may be part of the reason for the increase. They have demonstrated that drugs like Elavil, Claritin, Hismanal, Atarax, Unisom, Prozac, NyQuil, and Reactine have all resulted in tumors in animal studies. Some antihistamines behave like the drug DPPE, which has been linked to enhancing tumor growth by binding to histamine receptors, which in turn interferes with enzymes designed to detoxify and remove poisons from the body. This will also interfere with the system that regulates cell growth. The drugs do not necessarily cause cancer, but can enhance the growth of cancer.
Histoplex AB® is a natural antihistamine used primarily for air-borne allergies and contains a proprietary blends of herbs used to support inflammatory problems, treatment of the mouth and throat, congestion and chronic phlegm and has also been used effectively with certain types of asthma.